Remdesivir is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences.It is an experimental drug. First developed as a treatment for Ebola, it works by confusing the virus as it looks chemically similar to some of the raw materials the virus needs to replicate.

It is administered via injection into a vein.During the 2020 COVID-19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID‑19 in around 50 countries.

In late October, the U.S. Food and Drug Administration (FDA) officially approved the antiviral medication remdesivir to treat COVID-19, making it the first FDA approved drug for COVID-19.

After the U.S. President Donald Trump and his personal lawyer Rudy Giuliani, were infected with SARS-CoV-2, they were both treated with remdesivir as one of the treatments. More…

Casirivimab/imdevimab(Antibody Cocktail)

Casirivimab/imdevimab antibody cocktail is an experimental medicine developed by the American biotechnology company Regeneron Pharmaceuticals.

It is an artificial “antibody cocktail” designed to produce resistance to the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic.It consists of a mixture of two monoclonal antibodies, casirivimab (REGN10933) and imdevimab (REGN10987).The combination of two antibodies is intended to prevent mutational escape.

In November 2020, Regeneron’s casirivimab and imdevimab antibody cocktail (formerly known as REGN-COV2 or REGEN-COV2), received Emergency Use Authorization (EUA) from the U.S. FDA.